Clene (CLNN) Assets (2019 - 2026)
Clene (CLNN) posted Assets of $23.0 million for Q2 2026, up 27.08% on a QoQ basis from $18.1 million in Q4 2025, and up 4.14% year-over-year from $22.1 million in Q2 2025.
Analysis
Clene (CLNN) Assets (2019 - 2026) Analysis & Trends
Clene has reported Assets for 8 years, with the latest figure at $23.0 million in Q2 2026.
- On a quarterly basis, Assets rose 4.14% year-over-year to $23.0 million in Q2 2026; TTM through Jun 2026 was $23.0 million, a 4.14% increase from a year earlier, with the FY2025 full-year figure at $18.1 million, down 33.68% from the prior year.
- Assets was $23.0 million for Q2 2026 at Clene, up from $18.1 million in the prior quarter.
- The five-year high for Assets was $67.8 million in Q2 2023, with the low at $18.1 million in Q4 2025.
- Average Assets over 5 years is $38.5 million, with a median of $39.9 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Assets plunged 50.7% in 2022, then soared 67.85% in 2023.
- Over 5 years, Assets stood at $44.5 million in 2022, then rose by 17.64% to $52.3 million in 2023, then slumped by 47.77% to $27.3 million in 2024, then sank by 33.68% to $18.1 million in 2025, then advanced by 27.08% to $23.0 million in 2026.
- The last three Assets figures came in at $23.0 million (Q2 2026), $18.1 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 201.13 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 150.01 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 4.32 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 7.87 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 7.22 Bn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 23.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.04 Mn |
| Dec 31, 2025 | 18.13 Mn |
| Sep 30, 2025 | 22.31 Mn |
| Jun 30, 2025 | 22.13 Mn |
| Mar 31, 2025 | 25.31 Mn |
| Dec 31, 2024 | 27.34 Mn |
| Sep 30, 2024 | 31.57 Mn |
| Jun 30, 2024 | 40.33 Mn |
| Mar 31, 2024 | 45.07 Mn |
| Dec 31, 2023 | 52.34 Mn |
| Sep 30, 2023 | 60.43 Mn |
| Jun 30, 2023 | 67.85 Mn |
| Mar 31, 2023 | 39.89 Mn |
| Dec 31, 2022 | 44.49 Mn |
| Sep 30, 2022 | 36.00 Mn |
| Jun 30, 2022 | 44.54 Mn |
| Mar 31, 2022 | 53.36 Mn |
| Dec 31, 2021 | 63.06 Mn |
| Sep 30, 2021 | 73.04 Mn |
| Jun 30, 2021 | 73.28 Mn |